Narcolepsy Therapeutics Market By Type and Product - Global Industry Analysis And Forecast To 2025

Published On : October 2018 Pages : 180 Category: Pharmaceuticals Report Code : HC101500

Narcolepsy Therapeutics Market By Type (Narcolepsy With Cataplexy, Secondary Narcolepsy and Narcolepsy Without Cataplexy) and Product (Tricyclic Antidepressants, Central Nervous System Stimulants, Selective Serotonin Reuptake Inhibitor, Sodium Oxybate and Other Products) - Global Industry Analysis And Forecast To 2025

Industry Outlook

The narcolepsy is the chronic disorder related to neurology and the results from the failure of the body to manage the rest wake cycles. The Narcoleptics encounter the inclinations to rest for the duration of the day, and if these desires wind up overpowering, this can result in sporadic periods of rest. These rest periods may run from seconds or few minutes and in the most outrageous cases here and there hours at single time. Since those which experience the ill effects of this issue can nod off at whenever, narcolepsy is the unbelievably upsetting to the everyday working. Therefore, the Narcolepsy Therapeutics Market is anticipated to expand and has tremendous scope during the forecast period. The global Narcolepsy Therapeutics Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

Based on Type the market is segmented into Narcolepsy With Cataplexy, Secondary Narcolepsy and Narcolepsy Without Cataplexy. The section Narcolepsy With Cataplexy is leading the global market due to rising cases of cataplexy which is the primary symptom seen in patients.

Based on Product the market is segmented into Tricyclic Antidepressants, Central Nervous System Stimulants, Selective Serotonin Reuptake Inhibitor, Sodium Oxybate and Other Products. The Sodium Oxybate sections is dominating the global market due to rising cost of the drugs, increasing awareness amongst the people for the diagnosis & treatments, presence of refunding policies, etc.

Regional Insights

The European region is leading the global Narcolepsy Therapeutics Market owing to factors like; more number of people affected by the disease, well-developed healthcare sector, rising activities of research & development for the production of mare targeted medications, etc.

Narcolepsy Therapeutics Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • BIOPROJET
  • Teva Pharmaceutical Industries Ltd.
  • Graymark Healthcare Inc.
  • Jazz Pharmaceuticals PLC
  • Addrenex Pharmaceuticals Inc.

Some of the key questions answered by the report are:          

  • What was the market size in 2014 and forecast from 2015 to 2025?
  • What will be the industry market growth from 2015 to 2025?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Narcolepsy Therapeutics MarketClassification

o   Narcolepsy Therapeutics Market, By Type, Estimates and Forecast, 2014-2025 ($Million)

o   Narcolepsy With Cataplexy

o   Secondary Narcolepsy

o   Narcolepsy Without Cataplexy

o   Narcolepsy Therapeutics Market, By Product, Estimates and Forecast, 2014-2025 ($Million)

o   Tricyclic Antidepressants

o   Central Nervous System Stimulants

o   Selective Serotonin Reuptake Inhibitor

o   Sodium Oxybate

o   Other Products

o   Narcolepsy Therapeutics Market, By Region, Estimates and Forecast, 2014-2025 ($Million)

o   North America

§  North America Narcolepsy Therapeutics Market, By Country

o   U.S. Narcolepsy Therapeutics Market

o   Canada Narcolepsy Therapeutics Market

o   Mexico Narcolepsy Therapeutics Market

o   Europe

§  Europe Narcolepsy Therapeutics Market, By Country

o   Germany Narcolepsy Therapeutics Market

o   UK Narcolepsy Therapeutics Market

o   France Narcolepsy Therapeutics Market

o   Russia Narcolepsy Therapeutics Market

o   Italy Narcolepsy Therapeutics Market

o   Rest of Europe Narcolepsy Therapeutics Market

o   Asia-Pacific

§  Asia-Pacific Narcolepsy Therapeutics Market, By Country

o   China Narcolepsy Therapeutics Market

o   Japan Narcolepsy Therapeutics Market

o   South Korea  Narcolepsy Therapeutics Market

o   India Narcolepsy Therapeutics Market

o   Southeast Asia Narcolepsy Therapeutics Market

o   Rest of Asia-Pacific Narcolepsy Therapeutics Market

o   South America

§  South America Narcolepsy Therapeutics Market, By Country

o   Brazil Narcolepsy Therapeutics Market

o   Argentina Narcolepsy Therapeutics Market

o   Columbia Narcolepsy Therapeutics Market

o   Rest of South America Narcolepsy Therapeutics Market

o   Middle East and Africa

§  Middle East and Africa Narcolepsy Therapeutics Market, By Country

o   Saudi Arabia Narcolepsy Therapeutics Market

o   UAE Narcolepsy Therapeutics Market

o   Egypt Narcolepsy Therapeutics Market

o   Nigeria Narcolepsy Therapeutics Market

o   South Africa Narcolepsy Therapeutics Market

o   Rest of MEA Narcolepsy Therapeutics Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2014-2025)

4.1.2.  Canada Market Status and Outlook (2014-2025)

4.1.3.  Mexico Market Status and Outlook (2014-2025)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2014-2025)

4.2.2.  France Market Status and Outlook (2014-2025)

4.2.3.  UK Market Status and Outlook (2014-2025)

4.2.4.  Russia Market Status and Outlook (2014-2025)

4.2.5.  Italy Market Status and Outlook (2014-2025)

4.2.6.  Rest of Europe Market Status and Outlook (2014-2025)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2014-2025)

4.3.2.  Japan Market Status and Outlook (2014-2025)

4.3.3.  Korea Market Status and Outlook (2014-2025)

4.3.4.  India Market Status and Outlook (2014-2025)

4.3.5.  Southeast Asia Market Status and Outlook (2014-2025)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2014-2025)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2014-2025)

4.4.2.  Argentina Market Status and Outlook (2014-2025)

4.4.3.  Columbia Market Status and Outlook (2014-2025)

4.4.4.  Rest of South America Market Status and Outlook (2014-2025)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2014-2025)

4.5.2.  United Arab Emirates Market Status and Outlook (2014-2025)

4.5.3.  Egypt Market Status and Outlook (2014-2025)

4.5.4.  Nigeria Market Status and Outlook (2014-2025)

4.5.5.  South Africa Market Status and Outlook (2014-2025)

4.5.6.  Turkey Market Status and Outlook (2014-2025)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2014-2025)

5.       Narcolepsy Therapeutics Market, By Type

5.1.     Introduction

5.2.     Global Narcolepsy Therapeutics Revenue and Market Share by Type (2014-2018)

5.2.1.  Global Narcolepsy Therapeutics Revenue and Revenue Share by Type (2014-2018)

5.3.     Narcolepsy With Cataplexy

5.3.1.  Global Narcolepsy With Cataplexy Revenue and Growth Rate (2014-2018)

5.4.     Secondary Narcolepsy

5.4.1.  Global Secondary Narcolepsy  Revenue and Growth Rate (2014-2018)

5.5.     Narcolepsy Without Cataplexy

5.5.1.  Global Narcolepsy Without Cataplexy Revenue and Growth Rate (2014-2018)

6.       Narcolepsy Therapeutics Market, By Product

6.1.     Introduction

6.2.     Global Narcolepsy Therapeutics Revenue and Market Share by Product (2014-2018)

6.2.1.  Global Narcolepsy Therapeutics Revenue and Revenue Share by Product (2014-2018)

6.3.     Tricyclic Antidepressants

6.3.1.  Global Tricyclic Antidepressants Revenue and Growth Rate (2014-2018)

6.4.     Central Nervous System Stimulants

6.4.1.  Global Central Nervous System Stimulants Revenue and Growth Rate (2014-2018)

6.5.     Selective Serotonin Reuptake Inhibitor

6.5.1.  Global Selective Serotonin Reuptake Inhibitor Revenue and Growth Rate (2014-2018)

6.6.     Sodium Oxybate

6.6.1.  Global Sodium Oxybate Revenue and Growth Rate (2014-2018)

6.7.     Other Products

6.7.1.  Global Other Products Revenue and Growth Rate (2014-2018)

7.       Narcolepsy Therapeutics Market, By Region

7.1.     Introduction

7.2.     Global Narcolepsy Therapeutics Revenue and Market Share by Regions

7.2.1.  Global Narcolepsy Therapeutics Revenue by Regions (2014-2018)

7.3.     North America Narcolepsy Therapeutics by Countries

7.3.1.  North America Narcolepsy Therapeutics Revenue and Growth Rate (2014-2018)

7.3.2.  North America Narcolepsy Therapeutics Revenue (Million USD) by Countries (2014-2018)

7.3.3.  United States

7.3.3.1.  United States Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.3.4.  Canada

7.3.4.1.  Canada Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.3.5.  Mexico

7.3.5.1.  Mexico Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.     Europe Narcolepsy Therapeutics by Countries

7.4.1.  Europe Narcolepsy Therapeutics Revenue and Growth Rate (2014-2018)

7.4.2.  Europe Narcolepsy Therapeutics Revenue (Million USD) by Countries (2014-2018)

7.4.3.  Germany

7.4.3.1.  Germany Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.4.  France

7.4.4.1.  France Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.5.  UK

7.4.5.1.  UK Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.6.  Russia

7.4.6.1.  Russia Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.7.  Italy

7.4.7.1.  Italy Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.     Asia-Pacific Narcolepsy Therapeutics by Countries

7.5.1.  Asia-Pacific Narcolepsy Therapeutics Revenue and Growth Rate (2014-2018)

7.5.2.  Asia-Pacific Narcolepsy Therapeutics Revenue (Million USD) by Countries (2014-2018)

7.5.3.  China

7.5.3.1.  China Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.4.  Japan

7.5.4.1.  Japan Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.5.  Korea

7.5.5.1.  Korea Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.6.  India

7.5.6.1.  India Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.     South America Narcolepsy Therapeutics by Countries

7.6.1.  South America Narcolepsy Therapeutics Revenue and Growth Rate (2014-2018)

7.6.2.  South America Narcolepsy Therapeutics Revenue (Million USD) by Countries (2014-2018)

7.6.3.  Brazil

7.6.3.1.  Brazil Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.4.  Argentina

7.6.4.1.  Argentina Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.5.  Columbia

7.6.5.1.  Columbia Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.     Middle East and Africa Narcolepsy Therapeutics by Countries

7.7.1.  Middle East and Africa Narcolepsy Therapeutics Revenue and Growth Rate (2014-2018)

7.7.2.  Middle East and Africa Narcolepsy Therapeutics Revenue (Million USD) by Countries (2014-2018)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.5.  Egypt

7.7.5.1.  Egypt Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.7.  South Africa

7.7.7.1.  South Africa Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.8.  Turkey

7.7.8.1.  Turkey Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)

8.       Company Profiles

8.1.     BIOPROJET

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.   Revenue and Market Share

8.2.     Teva Pharmaceutical Industries Ltd.

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.   Revenue and Market Share

8.3.     Graymark Healthcare Inc.

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.   Revenue and Market Share

8.4.     Jazz Pharmaceuticals PLC

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.   Revenue and Market Share

8.5.     Addrenex Pharmaceuticals Inc.

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.   Revenue and Market Share

9.       Global Narcolepsy Therapeutics Market Competition, by Manufacturer

9.1.     Global Narcolepsy Therapeutics Revenue and Market Share by Manufacturer (2016-2017)

9.2.     Global Narcolepsy Therapeutics Price By Region (2016-2017)

9.3.     Top 5 Narcolepsy Therapeutics Manufacturer Market Share

9.4.     Market Competition Trend

10.    Narcolepsy Therapeutics Market Forecast (2018-2025)

10.1. Global Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2018-2025)

10.2. Narcolepsy Therapeutics Market Forecast by Regions (2018-2025)

10.2.1.      North America Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.1.1. United States Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.1.2. Canada Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.1.3. Mexico Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.2.      Europe Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.2.1. Germany Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.2.2. France Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.2.3. UK Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.2.4. Russia Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.2.5. Italy Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.2.6. Rest of Europe Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.3.      Asia-Pacific Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.3.1. China Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.3.2. Japan Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.3.3. Korea Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.3.4. India Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.3.5. Southeast Asia Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.3.6. Rest of Asia-Pacific Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.4.      South America Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.4.1. Brazil Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.4.2. Argentina Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.4.3. Columbia Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.4.4. Rest of South America Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.5.      Middle East and Africa Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.5.1. Saudi Arabia Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.5.2. United Arab Emirates Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.5.3. Egypt Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.5.4. Nigeria Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.5.5. South Africa Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.5.6. Turkey Narcolepsy Therapeutics Market Forecast (2018-2025)

10.2.5.7. Rest of Middle East and Africa Narcolepsy Therapeutics Market Forecast (2018-2025)

10.3. Narcolepsy Therapeutics Market Forecast by Type (2018-2025)

10.3.1.      Narcolepsy Therapeutics Forecast by Type (2018-2025)

10.3.2.      Narcolepsy Therapeutics Market Share Forecast by Type (2018-2025)

10.4. Narcolepsy Therapeutics Market Forecast by Product (2018-2025)

10.4.1.      Narcolepsy Therapeutics Forecast by Product (2018-2025)

10.4.2.      Narcolepsy Therapeutics Market Share Forecast by Product (2018-2025)


List of Tables

List of Tables and Figures:

Figure United States Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Canada Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Mexico Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Germany Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure France Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure UK Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Russia Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Italy Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Europe Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Korea Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Asia-Pacific Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Brazil Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Argentina Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Columbia Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of South America Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Saudi Arabia Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure United Arab Emirates Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Egypt Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Nigeria Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure South Africa Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Turkey Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Middle East and Africa Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2014-2025)
Table Global Narcolepsy Therapeutics Revenue and Revenue Share by Type (2014-2018)
Figure Global Narcolepsy With Cataplexy Revenue and Growth Rate (2014-2018)
Figure Global Secondary Narcolepsy Revenue and Growth Rate (2014-2018)
Figure Global Narcolepsy Without Cataplexy Revenue and Growth Rate (2014-2018)
Table Global Narcolepsy Therapeutics Revenue and Revenue Share by Product (2014-2018)
Figure Global Tricyclic Antidepressants Revenue and Growth Rate (2014-2018)
Figure Global Central Nervous System Stimulants Revenue and Growth Rate (2014-2018)
Figure Global Selective Serotonin Reuptake Inhibitor Revenue and Growth Rate (2014-2018)
Figure Global Sodium Oxybate Revenue and Growth Rate (2014-2018)
Figure Global Other Products Revenue and Growth Rate (2014-2018)
Table Global Narcolepsy Therapeutics Revenue by Regions (2014-2018)
Figure North America Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure North America Narcolepsy Therapeutics Revenue and Growth Rate (2014-2018)
Figure North America Narcolepsy Therapeutics by Countries (2014-2018)
Figure North America Narcolepsy Therapeutics Revenue (Million USD) by Countries (2014-2018)
Figure United States Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure United States Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Canada Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure Canada Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Mexico Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure Mexico Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Europe Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure Europe Narcolepsy Therapeutics Revenue and Growth Rate (2014-2018)
Figure Europe Narcolepsy Therapeutics by Countries (2014-2018)
Figure Europe Narcolepsy Therapeutics Revenue (Million USD) by Countries (2014-2018)
Figure Germany Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure Germany Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure France Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure France Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure UK Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure UK Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Russia Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure Russia Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Italy Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure Italy Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Europe Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure Rest of Europe Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Asia-Pacific Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure Asia-Pacific Narcolepsy Therapeutics Revenue and Growth Rate (2014-2018)
Figure Asia-Pacific Narcolepsy Therapeutics by Countries (2014-2018)
Figure Asia-Pacific Narcolepsy Therapeutics Revenue (Million USD) by Countries (2014-2018)
Figure China Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure China Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Japan Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure Japan Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Korea Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure Korea Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure India Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure India Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Southeast Asia Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure Southeast Asia Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South America Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure South America Narcolepsy Therapeutics Revenue and Growth Rate (2014-2018)
Figure South America Narcolepsy Therapeutics by Countries (2014-2018)
Figure South America Narcolepsy Therapeutics Revenue (Million USD) by Countries (2014-2018)
Figure Brazil Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure Brazil Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Argentina Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure Argentina Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Columbia Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure Columbia Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of South America Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure Rest of South America Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Middle East and Africa Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure Middle East and Africa Narcolepsy Therapeutics Revenue and Growth Rate (2014-2018)
Figure Middle East and Africa Narcolepsy Therapeutics by Countries (2014-2018)
Figure Middle East and Africa Narcolepsy Therapeutics Revenue (Million USD) by Countries (2014-2018)
Figure Saudi Arabia Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure Saudi Arabia Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure United Arab Emirates Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure United Arab Emirates Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Egypt Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure Egypt Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Nigeria Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure Nigeria Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South Africa Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure South Africa Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Turkey Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure Turkey Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Narcolepsy Therapeutics Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
Table BIOPROJET Narcolepsy Therapeutics Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Graymark Healthcare Inc. Narcolepsy Therapeutics Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Addrenex Pharmaceuticals Inc. Narcolepsy Therapeutics Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Narcolepsy Therapeutics Market Share by Manufacturer
Figure Global Narcolepsy Therapeutics Revenue and Market Share by Manufacturer
Table Global Narcolepsy Therapeutics Price by Region (2016-2017)
Figure Top 5 Narcolepsy Therapeutics Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Narcolepsy Therapeutics Revenue (Millions USD) and Growth Rate (2018-2025)
Table Narcolepsy Therapeutics Market Forecast by Regions (2018-2025)
Figure North America Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure United States Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure Canada Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure Mexico Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure Europe Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure Germany Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure France Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure UK Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure Russia Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure Italy Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure Rest of Europe Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure Asia-Pacific Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure China Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure Japan Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure Korea Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure India Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure Southeast Asia Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure South America Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure Brazil Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure Argentina Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure Columbia Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure Rest of South America Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure Middle East and Africa Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure Saudi Arabia Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure United Arab Emirates Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure Egypt Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure Nigeria Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure South Africa Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure Turkey Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Narcolepsy Therapeutics Market Forecast (2018-2025)
Figure Global Narcolepsy Therapeutics Forecast by Type (2018-2025)
Figure Global Narcolepsy Therapeutics Market Share Forecast by Type (2018-2025)
Figure Global Narcolepsy Therapeutics Forecast by Type (2018-2025)
Figure Global Narcolepsy Therapeutics Forecast by Product (2018-2025)
Figure Global Narcolepsy Therapeutics Market Share Forecast by Product (2018-2025)
Figure Global Narcolepsy Therapeutics Forecast by Product (2018-2025)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*